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1. No more controversies, the skin cancer epidemic is real.  
(This manuscript)
2. Burden of disease is more than the incidence and mortality rates. 
(This manuscript)
3. An aspirin a day will not keep the cancer away. 
(This manuscript)
4. Chemoprevention studies are not merely the inverse of pharmacovigilance studies.  
(This manuscript)
5. A perfect chemopreventive drug has several health benefits and minimal risks.  
(This manuscript)
6. P-values are useless.  
(Lang et al., Epidemiology, 1998)
7. Chronic aspirin is effective, if data are massaged sufficiently.  
(Cleland, BMJ, 2002)
8. Negative or null trials are not failures.  
(Patterson et al., Clin. Chem.,2013)
9. It is more important to control for confounding factors than to overcome insufficient 
power. 
(Yang, JCO, 2011)
10. Confounding by sun exposure is overestimated in observational chemoprevention 
studies for skin cancer. 
(Curiel-Lewandrowski et al., JID, 2011) 
11. The aim of this thesis was Jita Kyoei (自他共栄) and writing this thesis sometimes felt 
like the opposite of Seiryoku Zenyo (精力善用).
(Principles of judo: 自他共栄 (mutual welfare and benefit), 精力善用 (maximum effect 
with minimum effort), Jigoro Kano 1860-1938)
